Sigma-1 receptor and seizures

被引:14
作者
Vavers, Edijs [1 ,2 ]
Zvejniece, Liga [1 ]
Dambrova, Maija [1 ,3 ]
机构
[1] Latvian Inst Organ Synth, Lab Pharmaceut Pharmacol, Aizkraukles 21, LV-1006 Riga, Latvia
[2] Univ Tartu, Inst Chem, Fac Sci & Technol, Ravila 14a, EE-50411 Tartu, Estonia
[3] Riga Stradins Univ, Fac Pharm, Konsula 21, LV-1007 Riga, Latvia
基金
欧盟地平线“2020”;
关键词
Sigma-1; receptor; Seizures; Sigma-1 receptor knockout; Sigma-1 receptor ligands; Seizure -related comorbidities; Multidimensional drug target; METHYL-D-ASPARTATE; COCAINE-INDUCED CONVULSIONS; DEXTROMETHORPHAN BINDING-SITES; GUINEA-PIG BRAIN; PHENCYCLIDINE-LIKE DRUGS; MORPHINE-LIKE ANALGESICS; KAINATE-INDUCED SEIZURES; GATED CALCIUM-CHANNELS; ANTICONVULSANT PROPERTIES; ALLOSTERIC MODULATION;
D O I
10.1016/j.phrs.2023.106771
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the last decade, sigma-1 receptor (Sig1R) has been recognized as a valid target for the treatment of seizure disorders and seizure-related comorbidities. Clinical trials with Sig1R ligands are underway testing therapies for the treatment of drug-resistant seizures, developmental and epileptic encephalopathies, and photosensitive ep-ilepsy. However, the direct molecular mechanism by which Sig1R modulates seizures and the balance between excitatory and inhibitory pathways has not been fully elucidated. This review article aims to summarize existing knowledge of Sig1R and its involvement in seizures by focusing on the evidence obtained from Sig1R knockout animals and the anti-seizure effects of Sig1R ligands. In addition, this review article includes a discussion of the advantages and disadvantages of the use of existing compounds and describes the challenges and future per-spectives on the use of Sig1R as a target for the treatment of seizure disorders.
引用
收藏
页数:27
相关论文
共 341 条
[1]   Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives [J].
Abatematteo, Francesca Serena ;
Niso, Mauro ;
Contino, Marialessandra ;
Leopoldo, Marcello ;
Abate, Carmen .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
[2]   ANTAGONISM OF VARIOUS TONIC CONVULSIONS IN MICE BY DEXTRORPHAN AND DIZOCILPINE [J].
AKAIKE, N ;
HIMORI, N .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (06) :652-657
[3]  
ALBERTSON TE, 1984, J PHARMACOL EXP THER, V228, P620
[4]   EFFECTS OF PHENOBARBITAL AND SC-13504 ON PARTIALLY KINDLED HIPPOCAMPAL SEIZURES IN RATS [J].
ALBERTSON, TE ;
PETERSON, SL ;
STARK, LG .
EXPERIMENTAL NEUROLOGY, 1978, 61 (02) :270-280
[5]   THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: OVERVIEW [J].
Alexander, Stephen P. H. ;
Benson, Helen E. ;
Faccenda, Elena ;
Pawson, Adam J. ;
Sharman, Joanna L. ;
McGrath, John C. ;
Catterall, William A. ;
Spedding, Michael ;
Peters, John A. ;
Harmar, Anthony J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (08) :1449-1458
[6]   Fluvoxamine alleviates seizure activity and downregulates hippocampal GAP-43 expression in pentylenetetrazole-kindled mice: role of 5-HT3 receptors [J].
Alhaj, Momen W. ;
Zaitone, Sawsan A. ;
Moustafa, Yasser M. .
BEHAVIOURAL PHARMACOLOGY, 2015, 26 (04) :369-382
[7]   Gamma-aminobutyric acid and glutamic acid receptors may mediate theophylline-induced seizures in mice [J].
Amabeoku, GJ .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1999, 32 (03) :365-372
[8]   Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice [J].
Amador, Ariadna ;
Bostick, Christopher D. ;
Olson, Heather ;
Peters, Jurrian ;
Camp, Chad R. ;
Krizay, Daniel ;
Chen, Wenjuan ;
Han, Wei ;
Tang, Weiting ;
Kanber, Ayla ;
Kim, Sukhan ;
Teoh, JiaJie ;
Sah, Megha ;
Petri, Sabrina ;
Paek, Hunki ;
Kim, Ana ;
Lutz, Cathleen M. ;
Yang, Mu ;
Myers, Scott J. ;
Bhattacharya, Subhrajit ;
Yuan, Hongjie ;
Goldstein, David B. ;
Poduri, Annapurna ;
Boland, Michael J. ;
Traynelis, Stephen F. ;
Frankel, Wayne N. .
BRAIN, 2020, 143 :2039-2057
[9]  
anavex, ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS
[10]  
anavex, NOVEL ANTISEIZURE CO